Gene · 8739
Papers1,778
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,778
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of diagnostic and therapeutic roles of programmed cell death-related proteins in dilated cardiomyopathy: a multi-omics and experimental validation study. | Sci Rep | 2026 | 42151293 | PubTator, text mining | PubMed |
| Exosome-derived hsa-miR-21-5p stimulates malignant progression of colorectal cancer by regulating HRK. | Biochem Biophys Res Commun | 2026 | 42033944 | PubTator, text mining | PubMed |
| In Vitro Cytotoxic Activity of Coleus hadiensis Methanolic Extract: Metabolic and Transcriptomic Effects in Lung Cancer Cell Line. | Molecules | 2026 | 41976117 | PubTator, text mining | PubMed |
| Loss of TRPV1 may shift capsaicin response from MAPK-CASC11-MYC protection to mitochondrial apoptosis in glioblastoma U87 cells. | Int J Biol Macromol | 2026 | 41967549 | PubTator, text mining | PubMed |
| Molecular mechanisms of exercise-induced improvements in Alzheimer's disease: a focus on lipid homeostasis. | Transl Neurodegener | 2026 | 41866584 | PubTator, text mining | PubMed |
| Enhancing cancer killing and natural killer cell persistence by targeting NOXA, a predictor of poor patient survival. | Mol Ther Oncol | 2026 | 41783357 | PubTator, text mining | PubMed |
| Efficacy and Safety of Gene Therapy for RPGR Gene-Associated X-Linked Retinitis Pigmentosa: A Systematic Review and Meta-Analysis. | Transl Vis Sci Technol | 2026 | 41773775 | PubTator, text mining | PubMed |
| PROTAC-based protein degradation: a window of opportunity for melanoma therapy. | J Biomed Sci | 2026 | 41761284 | PubTator, text mining | PubMed |
| Integrated bioinformatics and network search identify biomarkers and comorbid mechanisms of atrial fibrillation and ischemic stroke. | Medicine (Baltimore) | 2026 | 41760035 | PubTator, text mining | PubMed |
| Skin Organoids in Proteostasis Research: Early Insights into Aging. | Biomol Ther (Seoul) | 2026 | 41755770 | PubTator, text mining | PubMed |
| Inside the Battle Against Acute Myeloid Leukemia: Biology, Breakthroughs, and Hope. | Cells | 2026 | 41744781 | PubTator, text mining | PubMed |
| Pan-Cell Death Protein Signature as a Novel Diagnostic and Prognostic Biomarker for Intracerebral Hemorrhage. | J Proteome Res | 2026 | 41734295 | PubTator, text mining | PubMed |
| Differential expression of HRK regulates proliferation of acquired melanocytic naevi. | Br J Dermatol | 2026 | 41721651 | PubTator, text mining | PubMed |
| Time‑resolved multi-omic analysis of paclitaxel exposure in human iPSC‑derived sensory neurons unveils mechanisms of chemotherapy‑induced peripheral neuropathy. | Cell Death Dis | 2026 | 41667428 | PubTator, text mining | PubMed |
| The Metacarpophalangeal Pattern Profile: An Old Method With New Insights Into the Evaluation of Short Stature. | Am J Hum Biol | 2026 | 41623008 | PubTator, text mining | PubMed |
| Metformin-Mediated Glycaemic Regulation as a Potential Strategy for Breast Cancer Prevention. | Cancer Med | 2026 | 41603225 | PubTator, text mining | PubMed |
| Design, Synthesis, Molecular Docking, Dynamics Simulation, and Biological Evaluation of Novel Thiazolidinedione Derivatives Against Breast Cancer with Apoptosis-Inducing Activity. | ACS Omega | 2026 | 41552544 | PubTator, text mining | PubMed |
| Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasms. | J Immunother Cancer | 2026 | 41529908 | PubTator, text mining | PubMed |
| Activator of apoptosis harakiri (HRK) localisation at mitochondria alters mitochondrial morphology independently of other BCL-2 proteins. | FEBS J | 2026 | 40938785 | PubTator, text mining | PubMed |
| A thirty-year trend of increasing clinical orientation at the National Institutes of Health. | bioRxiv | 2025 | 41446214 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8739/papers